Jeffery A. Smisek, Director at Finch Therapeutics Group, Inc. (FNCH), sold 1,470 shares at $3.64 ($5K) on 2023-11-22, disclosed to the SEC on 2023-11-27.
Open-market sale of $5k FNCH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| UAL | BUY | 2014-04-28 | $792K | — | Filing → |
| UAL | BUY | 2013-08-27 | $250K | — | Filing → |
| NOV | SELL | 2013-03-15 | $115K | — | Filing → |